ArticleNature2020
COVID-19 vaccines: time to talk about the uncertainties.
Article in Nature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Evaluation of the diagnostic accuracy of COVID-19 antigen tests: A systematic review and meta-analysis.Journal of the Chinese Medical Association : JCMA · 2021Pooled it
- Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection.The Journal of antimicrobial chemotherapy · 2022Trial
- COVID-19 Vaccine Fact-Checking Posts on Facebook: Observational Study.Journal of medical Internet research · 2022Observational
- First computational design using lambda-superstrings and in vivo validation of SARS-CoV-2 vaccine.Scientific reports · 2022Article
- The COVID-19 Vaccine: Trust, doubt, and hope for a future beyond the pandemic in Germany.PloS one · 2022Article
- Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities.Proceedings of the National Academy of Sciences of the United States of America · 2021Article
- Treatment and prevention strategies for the COVID 19 pandemic: A review of immunotherapeutic approaches for neutralizing SARS-CoV-2.International journal of biological macromolecules · 2021Review
- The success of SARS-CoV-2 vaccines and challenges ahead.Cell host & microbe · 2021Review
- Perspectives in the study of the political economy of COVID-19 vaccine regulation.Regulation & governance · 2021Article
- COVID-19 vaccine challenges: What have we learned so far and what remains to be done?Health policy (Amsterdam, Netherlands) · 2021Review
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
33082537What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.